Literature DB >> 25543268

Biological features of biofilm-forming ability of Acinetobacter baumannii strains derived from 121 elderly patients with hospital-acquired pneumonia.

Duchao Zhang1,2, Jingjing Xia1,3, Yaping Xu4, Meiliang Gong4, Yu Zhou4, Lixin Xie2, Xiangqun Fang5.   

Abstract

This study is to investigate a biological activity of Acinetobacter baumannii isolates from sputum specimens of 121 elderly patients with hospital-acquired pneumonia. The ability of the isolates to form biofilms was quantitatively assessed by crystal violet staining, and adhesive property was examined using Giemsa staining. Biofilm-forming ability by the isolates was employed to test antimicrobial resistance and examine sources and clinical manifestations. The isolates grew as biofilm on abiotic surface at the indicated temperatures after a 48 h of incubation. 27.3 % of the isolates were strongly biofilm-positive in the samples, and 84.8 % displayed high adhesion ability (P < 0.05). All of the isolates showed antibiotic resistance at different levels, and the isolates produced strong biofilm exhibited low-level resistance to gentamicin, minocycline and ceftazidime (P < 0.05). The patients' experience in ICU, use of antibiotics and estimation of APACHE II (<17) were related to incidence of strong biofilm formation with no clinical manifestations found in the study. All clinical isolates are able to form biofilms which refer to adhesive efficiency and antibiotic resistance. Patient experiences in ICU surveillance, use of antibiotics and APACHE II scores are involved in biofilm-forming ability by the nosocomial pathogen derived from the hospitalized patients.

Entities:  

Keywords:  Acinetobacter baumannii; Adhesion ability; Antibiotic susceptibility; Biofilm-forming ability

Mesh:

Substances:

Year:  2014        PMID: 25543268     DOI: 10.1007/s10238-014-0333-2

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  24 in total

1.  Resistance-nodulation-cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454.

Authors:  S Magnet; P Courvalin; T Lambert
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

Review 2.  Bacterial biofilms: a common cause of persistent infections.

Authors:  J W Costerton; P S Stewart; E P Greenberg
Journal:  Science       Date:  1999-05-21       Impact factor: 47.728

3.  Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2005-02-15       Impact factor: 21.405

Review 4.  Acinetobacter baumannii: an emerging multidrug-resistant pathogen in critical care.

Authors:  Kerry Montefour; Jeanne Frieden; Sue Hurst; Cindy Helmich; Denielle Headley; Mary Martin; Deborah A Boyle
Journal:  Crit Care Nurse       Date:  2008-02       Impact factor: 1.708

5.  Epidemic bacteremia due to Acinetobacter baumannii in five intensive care units.

Authors:  C M Beck-Sagué; W R Jarvis; J H Brook; D H Culver; A Potts; E Gay; B W Shotts; B Hill; R L Anderson; M P Weinstein
Journal:  Am J Epidemiol       Date:  1990-10       Impact factor: 4.897

6.  Survival of bacteria under dry conditions; from a viewpoint of nosocomial infection.

Authors:  Y Hirai
Journal:  J Hosp Infect       Date:  1991-11       Impact factor: 3.926

7.  Acinetobacter baumannii: An Emerging and Important Pathogen.

Authors:  Marcella Alsan; Michael Klompas
Journal:  J Clin Outcomes Manag       Date:  2010-08

Review 8.  Biofilms: survival mechanisms of clinically relevant microorganisms.

Authors:  Rodney M Donlan; J William Costerton
Journal:  Clin Microbiol Rev       Date:  2002-04       Impact factor: 26.132

9.  Attachment to and biofilm formation on abiotic surfaces by Acinetobacter baumannii: involvement of a novel chaperone-usher pili assembly system.

Authors:  Andrew P Tomaras; Caleb W Dorsey; Richard E Edelmann; Luis A Actis
Journal:  Microbiology       Date:  2003-12       Impact factor: 2.777

10.  Capacity of multidrug-resistant clinical isolates of Acinetobacter baumannii to form biofilm and adhere to epithelial cell surfaces.

Authors:  H-W Lee; Y M Koh; J Kim; J-C Lee; Y-C Lee; S-Y Seol; D-T Cho; J Kim
Journal:  Clin Microbiol Infect       Date:  2007-11-13       Impact factor: 8.067

View more
  21 in total

1.  Genotyping and molecular characterization of clinical Acinetobacter baumannii isolates from a single hospital in Southwestern Iran.

Authors:  Ahmad Farajzadeh Sheikh; Mohammad Savari; Effat Abbasi Montazeri; Saeed Khoshnood
Journal:  Pathog Glob Health       Date:  2020-06-19       Impact factor: 2.894

2.  Dose Optimization of Colistin Combinations against Carbapenem-Resistant Acinetobacter baumannii from Patients with Hospital-Acquired Pneumonia in China by Using an In Vitro Pharmacokinetic/Pharmacodynamic Model.

Authors:  Xingchen Bian; Xiaofen Liu; Yuancheng Chen; Daijie Chen; Jian Li; Jing Zhang
Journal:  Antimicrob Agents Chemother       Date:  2019-03-27       Impact factor: 5.191

3.  Prevalence of and risk factors for multidrug-resistant Acinetobacter baumannii colonization among high-risk nursing home residents.

Authors:  Lona Mody; Kristen E Gibson; Amanda Horcher; Katherine Prenovost; Sara E McNamara; Betsy Foxman; Keith S Kaye; Suzanne Bradley
Journal:  Infect Control Hosp Epidemiol       Date:  2015-06-15       Impact factor: 3.254

4.  Virulence determinants and biofilm formation of Acinetobacter baumannii isolated from hospitalized patients.

Authors:  Amir Aliramezani; Mohammad Soleimani; Ramin Mazaheri Nezhad Fard; Farshad Nojoomi
Journal:  Germs       Date:  2019-09-02

5.  Hospital Acquired Pneumonia Due to Achromobacter spp. in a Geriatric Ward in China: Clinical Characteristic, Genome Variability, Biofilm Production, Antibiotic Resistance and Integron in Isolated Strains.

Authors:  Chao Liu; Fei Pan; Jun Guo; Weifeng Yan; Yi Jin; Changting Liu; Long Qin; Xiangqun Fang
Journal:  Front Microbiol       Date:  2016-05-09       Impact factor: 5.640

6.  Molecular characterization of β-lactamase genes in clinical isolates of carbapenem-resistant Acinetobacter baumannii.

Authors:  Kevin M Raible; Bhaswati Sen; Nancy Law; Tiffany E Bias; Christopher L Emery; Garth D Ehrlich; Suresh G Joshi
Journal:  Ann Clin Microbiol Antimicrob       Date:  2017-11-16       Impact factor: 3.944

7.  Association of virulence gene expression with colistin-resistance in Acinetobacter baumannii: analysis of genotype, antimicrobial susceptibility, and biofilm formation.

Authors:  Abbas Bahador; Zahra Farshadzadeh; Reza Raoofian; Masoumeh Mokhtaran; Babak Pourakbari; Maryam Pourhajibagher; Farhad B Hashemi
Journal:  Ann Clin Microbiol Antimicrob       Date:  2018-06-01       Impact factor: 3.944

8.  Wide distribution of carbapenem resistant Acinetobacter baumannii in burns patients in Iran.

Authors:  Zahra Farshadzadeh; Farhad B Hashemi; Sara Rahimi; Babak Pourakbari; Davoud Esmaeili; Mohammad A Haghighi; Ali Majidpour; Saeed Shojaa; Maryam Rahmani; Samira Gharesi; Masoud Aziemzadeh; Abbas Bahador
Journal:  Front Microbiol       Date:  2015-10-20       Impact factor: 5.640

9.  Growth Rate and Biofilm Formation Ability of Clinical and Laboratory-Evolved Colistin-Resistant Strains of Acinetobacter baumannii.

Authors:  Zahra Farshadzadeh; Behrouz Taheri; Sara Rahimi; Saeed Shoja; Maryam Pourhajibagher; Mohammad A Haghighi; Abbas Bahador
Journal:  Front Microbiol       Date:  2018-02-12       Impact factor: 5.640

10.  Biofilm formation is not associated with worse outcome in Acinetobacter baumannii bacteraemic pneumonia.

Authors:  Yung-Chih Wang; Tzu-Wen Huang; Ya-Sung Yang; Shu-Chen Kuo; Chung-Ting Chen; Chang-Pan Liu; Yuag-Meng Liu; Te-Li Chen; Feng-Yee Chang; Shih-Hsiung Wu; Chorng-Kuang How; Yi-Tzu Lee
Journal:  Sci Rep       Date:  2018-05-08       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.